))
Insilico Medicine: A Leader in AI-driven Pharma Innovation
Manage episode 412205627 series 3554501
内容由Teymour Boutros-Ghali and Felicia Hsu, Teymour Boutros-Ghali, and Felicia Hsu提供。所有播客内容（包括剧集、图形和播客描述）均由 Teymour Boutros-Ghali and Felicia Hsu, Teymour Boutros-Ghali, and Felicia Hsu 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
Insilico Medicine uses generative AI for drug discovery and has set the trend for AI in the pharmaceutical industry. They have developed an AI platform to identify novel targets and molecules, significantly reducing the time and cost of the drug discovery process. The company has a pipeline of novel molecules and drugs, with one asset in clinical trials for idiopathic pulmonary fibrosis (IPF). They’ve gained the trust of the pharma industry and have partnerships with big pharma and contract research organizations.
Story Notes:
- Introduction and Background of Insilico Medicine
- Understanding Generative AI
- Insilico Medicine's Approach to Drug Discovery
- The Visionary Leadership of Alex Zhavoronkov
To learn more, visit:
https://boldcapitalpartners.com/
5集单集
分享
